Author/Authors :
Balbi, Maurizio School of Medicine and Surgery - University of Milano Bicocca, Monza, Italy , Ristani, Adela Division of Radiology - University of Parma, Parma, Italy , Milanese, Gianluca Division of Radiology - University of Parma, Parma, Italy , Silva, Mario Division of Radiology - University of Parma, Parma, Italy , Eufrasia Ledda, Roberta Division of Radiology - University of Parma, Parma, Italy , Milone, Francesca Division of Radiology - University of Parma, Parma, Italy , Sartorio, Carlotta Division of Radiology - University of Parma, Parma, Italy , Tringali, Giulia Division of Radiology - University of Parma, Parma, Italy , Sverzellati, Nicola Division of Radiology - University of Parma, Parma, Italy
Abstract :
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus responsible for the coronavirus disease 2019 (COVID-19), a respiratory disease that ranges from an asymptomatic or mild flu-like illness to severe pneumonia, multiorgan failure, and death. Imaging might play an important role in clinical decision making by supporting rapid triage of patients with suspected COVID-19 and assessing supervening complications, such as super-added bacterial infection and thrombosis. Further studies will clarify the real im-pact of imaging on COVID-19 patients’ management and the potential role of radiology in future outbreaks. (www.actabiomedica.it)
Keywords :
COVID-19 , radiologist , diagnosing , Parma experiences
